NCT03603223: Pembrolizumab in Treating Participants With Leukoplakia
- State
- Under way
- Phase
- Phase 2
- People
- 26 planned
- Started
- 3 May 2019
- Primary completion
- 1 Aug 2027
- Arms
- Treatment (pembrolizumab)
- Results
- None posted
- 27 Jul 2018: Trial registered
- 3 May 2019: Trial started